As we age, the brain faces a gradual decline in synaptic density and in the neurotrophic support that keeps connections healthy. A growing area of geroscience asks whether we can do something about that directly. Neuroprotective peptides, short chains of amino acids, are being studied for their ability to reach the brain and engage the same repair and growth pathways the body already uses. Unlike most shelf supplements, the interest here is mechanistic and specific. Here is a clear look at the four most discussed compounds, and what the evidence supports for each.
1. Cerebrolysin · the clinical heavyweight
Overview Strongest evidence
Cerebrolysin is a peptide complex derived from purified porcine brain proteins. What makes it distinctive is that it does not target a single receptor: its low-molecular-weight fragments mimic several of the brain's own growth factors at once, including BDNF and NGF.
How it works It is described as multimodal, stabilizing neurons, reducing neuroinflammation, and supporting neurogenesis, the formation of new neurons, particularly in the hippocampus.
What the research shows It has the deepest research base of the four, with decades of clinical use across more than 45 countries. Pooled trial data point to meaningful gains in global function in vascular dementia, and randomized trials report improved recovery after stroke and traumatic brain injury. The injury findings are the strongest of these; the dementia signal, while genuinely positive, still rests on a relatively small set of trials, so it reads as promising rather than settled.
Practical notes It is generally well tolerated, but it must be given by intravenous or intramuscular injection, since oral forms are broken down before they reach the brain. It is not recommended for people with seizure disorders or severe kidney impairment.
2. Semax · the nootropic brain booster
Overview Emerging
Originally developed in Russia, Semax is a synthetic analog of a fragment of the hormone ACTH, engineered so that the original hormonal activity is gone.
How it works Rather than binding neurotrophin receptors directly, it appears to trigger a rapid rise in BDNF in the hippocampus, an effect shown clearly in animal models. In laboratory studies it also binds copper in a way that reduces amyloid-beta clumping, a mechanism of real interest for neurodegeneration.
What the research shows Early human imaging work suggests Semax may influence connectivity in the Default Mode Network, a brain network tied to cognitive processing, though this rests on limited data so far.
Practical notes It is typically used as a nasal spray, which makes it far more accessible than the injectable options.
3. Epitalon · the longevity peptide
Overview Preclinical
Epitalon, also spelled Epithalon, is a synthetic version of a peptide found in the pineal gland. It is widely discussed in longevity circles for its claimed effect on the cellular clock.
How it works Its signature mechanism is telomerase activation. In human cell cultures it has been shown to lengthen telomeres, the protective caps on our DNA, a result that an independent lab replicated in 2025. Whether that carries over to telomeres in living people is still unproven.
What the research shows The preclinical data is the interesting part, with increased lifespan reported in flies and rodents, but large-scale human cognitive trials are still lacking.
Practical notes Because it influences cell division, there is a theoretical concern about its use in people who may have undiagnosed cancers, even though some studies suggest it can also have anti-tumor effects. This is an open scientific question rather than a settled one, which is the honest way to hold it.
4. Dihexa · the synaptic hammer
Overview Research only
Dihexa is perhaps the most potent peptide being studied for building new synapses, and also the most experimental.
How it works It targets the HGF and c-Met pathway, a powerful system for cellular repair. In lab settings, Dihexa was measured to be millions of times more potent than BDNF at promoting synaptic connectivity. That figure is a potency comparison in cell cultures, not a real-world effect size, but it is striking nonetheless.
Status and cautions It is currently research-only. Its potential for treating Alzheimer's is high in principle, but its safety in humans has not been established, and because the c-Met pathway is also involved in cancer growth, it carries a theoretical risk tied to uncontrolled cell division. This is the compound where enthusiasm and evidence are furthest apart.
| Compound | Proposed mechanism | Human evidence | Status |
|---|---|---|---|
| Cerebrolysin | Mimics multiple growth factors (BDNF, NGF, others) | Positive, preliminary | Approved in 45+ countries; not FDA approved |
| Semax | Raises BDNF; lab-level anti-amyloid action | Early, limited | Approved in Russia; not in US or EU |
| Epitalon | Telomerase activation (shown in human cells) | No human cognitive trials | Not an approved therapy |
| Dihexa | HGF and c-Met driven synaptogenesis | None in humans yet | Research only |
The power of synergy: multi-modal integration
The research repeatedly suggests these peptides are most interesting when they are not used in isolation. A structured integration strategy aims to stack supportive conditions:
- 1Metabolic priming. Use intermittent fasting to encourage the brain's cellular cleanup process, autophagy, which clears damaged proteins and debris.
- 2Peptide timing. Introduce peptides such as Semax or Cerebrolysin during the refeeding phase, when the brain shifts from clearance toward building and repair.
- 3Neuromodulation. Early case evidence suggests pairing peptides with tDCS, transcranial direct current stimulation, may help direct where remodeling happens.
A note on professional guidance
The biohacking community often explores these tools independently, but the clinical consensus is clear: professional oversight matters. It is what ensures appropriate dosing, high-quality and verified sourcing, and screening for individual risk factors such as seizure thresholds, kidney function, and cardiovascular or cancer history. The mechanisms that make these compounds promising, growth and repair signaling, are also the mechanisms that demand respect. The right first step is a conversation with a qualified clinician, not an order from an anonymous supplier.